Identifícate
Grupos
Investigadores/as
Financiamento
Resultados
Oncología Traslacional
ONCTRAS
Institute of Cancer Research
Londres, Reino Unido
Estás en
Colaboracións
Institute of Cancer Research
Publicacións en colaboración con investigadores/as de Institute of Cancer Research (2)
2024
Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02
Advances in Therapy
2021
Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olaparib or placebo (SOLO1): a randomised, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 5, pp. 632-642
Contactar
Aviso legal
Axuda
translate
gl
arrow_drop_down
translate
gl
arrow_drop_down
es
ca
eu
en
fr
de